Therapeutic Update: Bispecific Antibodies and the Blood-Brain-Barrier Analyst Report, Podcast, Peter Bak, PhDBack Bay Life Science AdvisorsNovember 18, 2024Bispecific antibodies, Blood Brain Barrier, Pharmaceutical Development
Outsourced Pharma: The Pharmacological Treatment Pipeline For Traumatic Brain Injury BlogBack Bay Life Science AdvisorsDecember 13, 2021Pharmaceutical Development, Neurology, Drug Pipeline, FDA
